Where Do We Stand with Closed-Loop Systems and Their Challenges?
- 30 June 2020
- journal article
- research article
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 22 (7) , 485-491
Abstract
Treatments for type 1 diabetes have advanced significantly over recent years. There are now multiple hybrid closed-loop systems commercially available and additional systems are in development. Challenges remain, however. This review outlines the recent advances in closed-loop systems and outlines the remaining challenges, including post-prandial hyperglycemia and exercise-related dysglycemia.Keywords
This publication has 52 references indexed in Scilit:
- Incorporating an Exercise Detection, Grading, and Hormone Dosing Algorithm Into the Artificial Pancreas Using Accelerometry and Heart RateJournal of Diabetes Science and Technology, 2015
- Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trialThe Lancet Diabetes & Endocrinology, 2015
- Outpatient Glycemic Control with a Bionic Pancreas in Type 1 DiabetesNew England Journal of Medicine, 2014
- Feasibility of a Portable Bihormonal Closed-Loop System to Control Glucose Excursions at Home Under Free-Living Conditions for 48 HoursDiabetes Technology & Therapeutics, 2014
- Nocturnal Glucose Control with an Artificial Pancreas at a Diabetes CampNew England Journal of Medicine, 2013
- Resistance Versus Aerobic ExerciseDiabetes Care, 2013
- Effect of Pramlintide on Prandial Glycemic Excursions During Closed-Loop Control in Adolescents and Young Adults With Type 1 DiabetesDiabetes Care, 2012
- Hypoglycemia in Type 1 DiabetesDiabetes, 2010
- Novel Use of Glucagon in a Closed-Loop System for Prevention of Hypoglycemia in Type 1 DiabetesDiabetes Care, 2010
- Fully Automated Closed-Loop Insulin Delivery Versus Semiautomated Hybrid Control in Pediatric Patients With Type 1 Diabetes Using an Artificial PancreasDiabetes Care, 2008